tiprankstipranks
Kane Biotech Inc (TSE:KNE)
:KNE
Canadian Market
KNE
Kane Biotech
RESEARCH TOOLSreports
Want to see TSE:KNE full AI Analyst Report?

Kane Biotech (KNE) Ratios

1 Followers

Kane Biotech Ratios

TSE:KNE's free cash flow for Q4 2025 was C$5.63. For the 2025 fiscal year, TSE:KNE's free cash flow was decreased by C$ and operating cash flow was C$55.50. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Dec 23Mar 23
Liquidity Ratios
Current Ratio
 0.68 0.68 0.43 0.34 0.49
Quick Ratio
 0.47 0.47 0.27 0.32 0.37
Cash Ratio
 0.36 0.36 0.15 0.07 0.17
Solvency Ratio
 -0.74 -0.74 -0.68 -0.35 -0.37
Operating Cash Flow Ratio
 -1.30 -1.30 -1.71 -0.30 -0.48
Short-Term Operating Cash Flow Coverage
 -2.46 -2.46 -8.90 -0.46 -0.73
Net Current Asset Value
C$ -1.79MC$ -1.79MC$ -3.09MC$ -10.37MC$ -6.66M
Leverage Ratios
Debt-to-Assets Ratio
 0.84 0.84 0.92 1.63 1.22
Debt-to-Equity Ratio
 -3.09 -3.09 -1.41 -0.88 -1.05
Debt-to-Capital Ratio
 1.48 1.48 3.46 -7.13 20.51
Long-Term Debt-to-Capital Ratio
 -4.77 -4.77 -1.43 -0.14 -0.32
Financial Leverage Ratio
 -3.66 -3.66 -1.53 -0.54 -0.86
Debt Service Coverage Ratio
 -1.81 -1.81 -2.38 -0.39 -0.59
Interest Coverage Ratio
 -12.82 -12.82 -8.24 -2.76 -4.23
Debt to Market Cap
 0.31 0.30 0.10 0.74 0.53
Interest Debt Per Share
 0.02 0.02 0.02 0.07 0.06
Net Debt to EBITDA
 -0.48 -0.48 -0.52 -2.63 -1.95
Profitability Margins
Gross Profit Margin
-38.18%-38.18%41.91%73.48%901.68%
EBIT Margin
-727.40%-727.40%-188.66%-2246.83%-2044.86%
EBITDA Margin
-689.37%-689.37%-178.17%-2171.04%-1880.46%
Operating Profit Margin
-727.40%-727.40%-215.96%-2253.58%-2206.05%
Pretax Profit Margin
-661.24%-661.24%-214.88%-3062.39%-2565.92%
Net Profit Margin
-636.00%-636.00%-145.35%-3379.05%-2481.86%
Continuous Operations Profit Margin
-636.00%-636.00%-151.91%-3062.39%-2565.92%
Net Income Per EBT
96.18%96.18%67.64%110.34%96.72%
EBT Per EBIT
90.90%90.90%99.50%135.89%116.31%
Return on Assets (ROA)
-99.53%-99.53%-121.26%-88.61%-69.22%
Return on Equity (ROE)
374.19%364.51%185.64%47.68%59.64%
Return on Capital Employed (ROCE)
-1340.54%-1340.54%-5336.54%64.40%479.07%
Return on Invested Capital (ROIC)
-192.17%-192.17%-478.88%-179.47%-97.22%
Return on Tangible Assets
-125.65%-125.65%-154.46%-101.75%-81.15%
Earnings Yield
-47.93%-41.94%-20.53%-44.86%-35.81%
Efficiency Ratios
Receivables Turnover
 11.72 11.72 23.62 37.86 0.27
Payables Turnover
 0.85 0.85 1.02 0.09 2.08
Inventory Turnover
 1.17 1.17 3.21 0.16 1.64
Fixed Asset Turnover
 0.90 0.90 2.24 0.14 0.13
Asset Turnover
 0.16 0.16 0.83 0.03 0.03
Working Capital Turnover Ratio
 -0.86 -0.39 -0.49 -0.03 -0.06
Cash Conversion Cycle
 -85.15 -85.15 -229.16 -1.71K 1.40K
Days of Sales Outstanding
 31.13 31.13 15.45 9.64 1.36K
Days of Inventory Outstanding
 311.49 311.49 113.55 2.31K 222.02
Days of Payables Outstanding
 427.77 427.77 358.15 4.04K 175.30
Operating Cycle
 342.62 342.62 129.00 2.32K 1.58K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -0.02 -0.03 -0.02 -0.03
Free Cash Flow Per Share
 -0.02 -0.02 -0.03 -0.02 -0.03
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.01 1.00 1.03
Dividend Paid and CapEx Coverage Ratio
 -665.46 -665.46 -166.16 -349.61 -34.76
Capital Expenditure Coverage Ratio
 -665.46 -665.46 -166.16 -349.61 -34.76
Operating Cash Flow Coverage Ratio
 -1.41 -1.41 -1.79 -0.35 -0.44
Operating Cash Flow to Sales Ratio
 -7.61 -7.61 -1.98 -21.62 -19.42
Free Cash Flow Yield
-51.22%-50.24%-28.08%-28.79%-28.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.09 -2.38 -4.87 -2.23 -2.79
Price-to-Sales (P/S) Ratio
 14.88 15.17 7.08 75.32 69.31
Price-to-Book (P/B) Ratio
 -7.61 -8.69 -9.04 -1.06 -1.67
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.95 -1.99 -3.56 -3.47 -3.47
Price-to-Operating Cash Flow Ratio
 -1.74 -1.99 -3.58 -3.48 -3.57
Price-to-Earnings Growth (PEG) Ratio
 0.02 0.09 0.13 -0.19 0.13
Price-to-Fair Value
 -7.61 -8.69 -9.04 -1.06 -1.67
Enterprise Value Multiple
 -2.63 -2.68 -4.49 -6.10 -5.64
Enterprise Value
 7.77M 7.89M 16.66M 19.73M 16.62M
EV to EBITDA
 -2.63 -2.68 -4.49 -6.10 -5.64
EV to Sales
 18.15 18.44 8.01 132.44 106.01
EV to Free Cash Flow
 -2.38 -2.42 -4.03 -6.11 -5.31
EV to Operating Cash Flow
 -2.39 -2.42 -4.05 -6.12 -5.46
Tangible Book Value Per Share
 >-0.01 >-0.01 -0.02 -0.07 -0.04
Shareholders’ Equity Per Share
 >-0.01 >-0.01 -0.01 -0.08 -0.05
Tax and Other Ratios
Effective Tax Rate
 0.04 0.04 0.29 0.00 0.00
Revenue Per Share
 <0.01 <0.01 0.02 <0.01 <0.01
Net Income Per Share
 -0.02 -0.02 -0.02 -0.04 -0.03
Tax Burden
 0.96 0.96 0.68 1.10 0.97
Interest Burden
 0.91 0.91 1.14 1.36 1.25
Research & Development to Revenue
 2.03 2.03 0.93 8.64 6.72
SG&A to Revenue
 4.63 4.86 1.48 16.20 23.75
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 2.97 1.78
Income Quality
 1.20 1.20 1.30 0.64 0.80
Currency in CAD